@article{JTD26163,
author = {Jinlong Zhao and Dazhi Jiang and Jiahui Du and Peng Yang},
title = {Treatment of stage IIIA–N2 EGFR-mutant non-small cell lung adenocarcinoma},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {1},
year = {2018},
keywords = {},
abstract = {Lung cancer remains the leading cause of death worldwide and is the most common cancer both in incidence and mortality (1.35 million deaths annually). Lobectomy, along with hilar and mediastinal lymph node dissection, is the standard surgical treatment for lung cancer. Roughly 20–25% of patients diagnosed with non-small cell lung cancer (NSCLC) are suitable for surgical resection with curative intent (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/26163}
}